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Abstract 12	
Strongyle egg shedding consistency in horses and factors affecting consistency were 13	
investigated. Faecal samples were collected from 26 equine populations over one 14	
grazing season. Samples were collected on four ‘screening’ occasions (S1–S4) and 15	
FEC performed using a sensitive method (to 1 eggs per gram (epg) egg detection 16	
limit). On each screening occasion, FEC were assigned an egg shedding category: 1 17	
(<50 epg) to 7 (>500 epg); and a treatment category: <200 epg (no treatment) or ≥ 18	
200 epg (treatment). Rank changes in shedding and treatment categories between S1 19	
and subsequent screening occasions were calculated. Factors affecting the likelihood 20	
of an individual changing shedding or treatment category were assessed using 21	
multivariable logistic regression of FEC data from horses that had not received 22	
anthelmintic during the study. In total, 573 horses were sampled at S1, 468 at S2, 417 23	
at S3 and 83 at S4. Results showed that between S1 and S4, 73.5% (61/83) horses 24	
remained in the same egg shedding category and 94.0% (78/83) in the same treatment 25	
category. For horses that did not receive anthelmintic (n=304), 90.4% (225/304) 26	
remained in the same egg shedding category. Horses under 5 years-old were more 27	
likely to change egg shedding (odds ratio, OR 3.3, 95% CI: 1.22-8.46) and treatment 28	
(OR 2.8, 95% CI: 1.1-6.3) categories compared to older horses. These results suggest 29	
a high level of consistency in strongyle egg shedding in individuals within one 30	
season, and withholding anthelmintics from horses with negative or low (i.e. <50 epg) 31	
FEC does not appear to be associated with significant increases in egg shedding.  32	
 33	
 34	
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1. Introduction 37	
Anthelmintic resistant nematodes pose a threat to equine health and welfare. 38	
Targeting anthelmintic treatments to individual horses based on levels of nematode 39	
egg shedding is proposed to achieve control, whilst reducing anthelmintic use and 40	
selection for resistance. Helminth parasites are typically overdispersed in their hosts: 41	
i.e. relatively few individuals within populations are infected with the majority of the 42	
associated parasite population [1-4]. Strongyle nematodes in the large intestine are the 43	
most important equine parasites and have a high prevalence [5]. Overdispersion has 44	
been demonstrated for strongyle faecal egg counts (FEC) in horses, with most 45	
individuals shedding relatively low numbers of eggs [6-8]. This overdispersion 46	
underpins the rationale behind targeted anthelmintic treatment strategies [5, 9-10], 47	
whereby only horses identified as shedding above a specific threshold of eggs 48	
(typically ≥200 eggs per gram (epg)) are recommended for treatment.  Several studies 49	
have shown consistency in strongyle egg shedding patterns in individuals over time 50	
[7, 11-14], which could further enhance efficient targeting of anthelmintic treatments 51	
and reduce the required frequency of FEC testing. The aim here was to investigate 52	
strongyle egg shedding consistency in populations of horses in the UK that followed a 53	
targeted anthelmintic treatment programme, with a focus on horses identified as low 54	
strongyle egg shedders (<50 epg), to examine whether non-treatment of these 55	
individuals was associated with increases in egg shedding levels over time. This study 56	
also analysed factors associated with shedding consistency in individuals within these 57	
populations. A longitudinal cohort study design was used. 58	
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2. Materials and methods 60	
2.1. Study population 61	
During 2010–2012, 573 horses from 26 equine holdings (yards) in Scotland and 62	
England were recruited (see supplementary data). The number of individual’s resident 63	
on each yard ranged from 7-72 (median, 20 horses). Most horses (i.e. those on 19 64	
yards) received moxidectin prior to the start of the study, although all had received a 65	
macrocyclic lactone (ML) within the six months prior to the start of the study 66	
(n=573). On three yards, information on which anthelmintic was last administered 67	
was not supplied. Most horses were resident at livery yards (n=23 yards). The 68	
remainder comprised of a non-Thoroughbred stud farm, a sport horse yard and a 69	
rescue/welfare sanctuary. In total, 573 horses were screened at S1, 468 horses at S2 70	
and 417 at S3. A total of 83 horses on three yards were screened at S4. Each horse 71	
was assigned an age category. The age distribution was: foal (<2 years; n=26), 72	
youngster (≥2 and <5 years; n=68), adult (≥5 and < 18 years; n=418) and geriatric 73	
(≥18 years; n=61).  74	
 75	
All horses included in this study had access to grazing, were at pasture during the 76	
study and had been treated with a ML anthelmintic within the previous 6 months. 77	
Horses were at pasture for a minimum of eight hours per day, and were grazed on the 78	
same pastures for the duration of the trial (i.e. returned to the same pasture after 79	
sampling and treatment). Yards with a minimum of 10 horses were included and all 80	
horses were subject to the same anthelmintic treatment regimen (Section 2.2). Each 81	
yard was supplied with a questionnaire to provide information on the demographics 82	
(i.e. yard function, number of horses etc.), anthelmintic usage (frequency of treatment, 83	
last product used, type of deworming programme followed) and general management 84	
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practices. Yard managers were asked to supply the age of the horses included in the 85	
study, but not specific details on breed and sex. On all yards, the manager was the 86	
point of contact and was responsible for completion of the questionnaire, coordinating 87	
sample collection and postage, and administering anthelmintic treatments.  88	
 89	
2.2. Targeted treatment protocol 90	
Horses that were previously treated with anthelmintic were sampled after a minimum 91	
period of 18 weeks had elapsed after administration of moxidectin, or 14 weeks for 92	
ivermectin. The first sample (Screen 1, S1, n=573) was collected between February 93	
and March. Horses with FEC ≥200 epg were treated with pyrantel embonate 94	
following the manufacturer’s instructions (Strongid-P™a at a dose rate of 19mg/kg 95	
bodyweight). All horses were FEC screened 8-10 weeks later: this was based on a 6-96	
week strongyle egg reappearance period (ERP) for pyrantel embonate [15, 16], plus 97	
an additional two weeks (Screen 2, S2; May/June, n=468).  Horses with FEC ≥ 200 98	
epg at S2 were treated with ivermectin (Eqvalan® oral paste for horsesb; 0.2mg/kg). 99	
All horses were screened 10–12 weeks later based on an ivermectin strongyle ERP of 100	
8-10 weeks [15], plus two additional weeks (Screen 3, S3; August/September, 101	
n=417).  At this point, horses with a FEC of ≥200 epg were treated with moxidectin 102	
(Equest®c; 0.4 mg/kg). On some yards a fourth screen (S4; October/December, n=83) 103	
was performed on horses that had not received anthelmintic treatment following S3.   104	
 105	
2.3. Sample collection and faecal egg count methodology  106	
Samples were collected from freshly passed faeces and placed into individually 107	
labeled zip-lock bags. Yard managers were provided with instructions on how to 108	
collect, store and post the samples, and were asked to collect at least three boli from 109	
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freshly voided faeces and to place these into the bag, expelling air before sealing. The 110	
samples were sent immediately to the Moredun Research Institute and stored at 111	
approximately 4˚C. All samples were processed within 4 days of excretion to reduce 112	
the effect of egg degradation [17]. A modification of the salt flotation method (1.2 113	
specific gravity) with a detection limit down to 1 epg was used [18]. All samples were 114	
analysed in duplicate by taking two 10 ml aliquots from a 100 ml dilution of a well-115	
mixed 10 g sub-sample and an average taken to estimate the epg count.  116	
 117	
2.4. Data analysis 118	
2.4.1. Egg shedding and anthelmintic treatment categories 119	
Each FEC data point on each screening occasion (S1, S2, S3, S4) was assigned a 120	
shedding category: 1 (0–49 epg); 2 (50–99 epg); 3 (100–199 epg); 4 (200–299 epg); 5 121	
(300–399 epg); 6 (400–499 epg) and 7 (>500 epg). Each FEC data point was also 122	
assigned a treatment category: < 200 epg (0, no treatment) or ≥ 200 epg (1, 123	
treatment).   124	
 125	
2.4.2. Egg shedding consistency 126	
To assess shedding consistency, the rank change in shedding category between S1 and 127	
S2, S1 and S3 and S1 and S4 was calculated. For example, if the category was ranked 128	
as 1 for S1 and 6 for S2, the rank change would be 5. Conversely, if the category was 129	
measured as 6 for S1 and 3 for S3, the rank change would be -3. If the category 130	
remained the same, rank change assigned was 0.   131	
  132	
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2.4.3. Anthelmintic treatment consistency 133	
Treatment category consistency was determined across S1 and S2, S1 and S3 and S1 134	
and S4. If an individual’s FEC changed from < 200 epg to ≥ 200 epg between two 135	
sampling points, the rank assigned was 1. If it changed from ≥ 200 epg to < 200 epg, 136	
it was assigned as -1, and if it remained above or below the 200 epg threshold, was 137	
assigned 0.  138	
 139	
2.4.4. Egg shedding and treatment consistency analysis 140	
For each sampling occasion, the number and percentage of horses in each shedding 141	
and treatment category were calculated.  Further, the number and percentage of horses 142	
that were in each rank change category of shedding (-6 to 6) and treatment (-1, 0 or 1) 143	
between S1 and each subsequent screening occasion was calculated. To test if there 144	
was a significant difference (p<0.05) in the proportion of horses falling into each 145	
shedding and treatment category between screening occasions, a binomial test was 146	
performed using the prop.test function in RStudio. All analyses were performed in 147	
RStudio, version 2.15.1 (The R Foundation for Statistical Computing, 2012). The 148	
analysis that was applied to the anthelmintic-treated horses was applied to horses that 149	
had not received anthelmintic during the study to assess if no treatment was 150	
associated with lower shedding consistency and rising FEC over time. All horses 151	
included in this analysis had FEC < 200 epg at S1.  152	
 153	
2.4.5. Factors affecting egg shedding and anthelmintic treatment consistency 154	
The effect of age, last anthelmintic administered and number of weeks after the 155	
expected ERP of each anthelmintic on the likelihood of a horse changing shedding or 156	
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treatment category between S1 and S3 was assessed using multivariable logistic 157	
regression. Factors included in the initial model are shown in Table 1. Regression 158	
analysis was performed using the GLM function in R (RStudio, version 2.15.1 (The R 159	
Foundation for Statistical Computing, 2012)), specifying the family as binomial, 160	
linked to logit transformation, g, where P is the probability of a horse changing 161	
shedding or treatment category, βi is the model (slope) coefficient and Xi is the 162	
explanatory variable (Equation 1). 163	
g = ln[P/(1-P)] = β0+ β1 X0+...+ βk Xk 164	
Equation 1 165	
The probability of a change in egg shedding and treatment category was estimated 166	
using Equation 2. 167	
P=exp[β0+ β1 X0+...+ βk Xk]/(1+exp[β0+ β1 X0+...+ βk Xk]) 168	
Equation 2 169	
Regression models were initially populated with all potential explanatory variables 170	
(age category, last treatment, time in weeks since expected ERP elapsed, Table 1), 171	
then variables with the highest, non-significant p-values removed in a stepwise 172	
process until a model with only significant terms remained. The effect of removing 173	
factors from the model was evaluated using log-likelihood ratio tests (LRT) [19, 20]. 174	
P-values (Wald) of ≤0.05 indicated factors that had a significant influence on 175	
changing shedding or treatment category in the final model. The Hosmer-Lemeshow 176	
test [21] was used to assess overall model fit using the ‘ResourceSelection’ package 177	
[22].  178	
  179	
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3. Results 180	
 181	
3.1. Consistency of strongyle egg shedding and treatment with anthelmintic 182	
At S1, 70.0% (401/573) of horses were shedding less than 50 epg (Figure 1a). This 183	
level of shedding was not significantly different at S2 (65.0%, 304/468) and S3 184	
(66.2%, 276/417), with the proportions in shedding categories 2 and 3 also not 185	
significantly different compared to S1. The percentage of horses in category 7 was 186	
low compared to the percentage of horses in category 1: for example, 5.8% (33/573) 187	
at S1 and 0.0% (0/83) at S4. On each occasion, the percentage of horses in the ‘no 188	
treatment’ category ranged from 83.6% (479/573) at S1 to 91.6% (76/83) at S4 189	
(Figure 1b).  190	
 191	
3.2. Egg shedding and treatment consistency 192	
Most horses remained in the same egg shedding and treatment category over time 193	
(Figure 2a). From S1 to S2, 61.5% horses (288/468) remained in the same shedding 194	
category; from S1-S3, 58.3% (243/417), and from S1-S4, 73.5% (61/83). Between S1 195	
and S2, 16.6% (77/468) horses moved to a lower shedding category and 22.0% 196	
(103/468) to a higher shedding category. Between S1 and S3, 23.7% (99/417) moved 197	
into a lower shedding category and 18.0% (75/417) moved into a higher shedding 198	
category. Between S1 and S4, 14.5% (12/83) horses moved into a lower shedding 199	
category and 8.3% (10/83) individuals moved to a higher shedding category.  200	
Between S1 and S2, S1 and S3 and S1 and S4, 81.8% (383/468), 82.7% (345/417) 201	
and 94.0% (78/83) horses remained in the same treatment category, respectively 202	
(Figure 2b). The egg shedding consistency in a sub-group that did not receive 203	
anthelmintic during the entire study (n=304) was investigated. The proportion of 204	
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horses shedding < 50 epg at S1 was 97.3% (296/304), at S2, 84.9% (258/304) and at 205	
S3, 85.5% (213/249). The change in proportion of horses shedding <50 epg was 206	
consistent throughout the study (p>0.05). Between S1 and S2, 92.1% (280/304) 207	
horses remained in the same shedding category, 0.3% (1/304) were in a lower 208	
shedding category and 7.9% (23/304) in a higher shedding category. Between S1 and 209	
S3, the percentage of horses that remained in the same shedding category was 90.4% 210	
(225/304) and the percentage of horses that were in a higher shedding category was 211	
9.6% (24/304).  212	
 213	
3.3. Factors associated with changing strongyle egg shedding category or treatment 214	
category over time 215	
Only horses (n=346) for which information on age and last anthelmintic treatment 216	
were available were included in these analyses. Factors affecting the likelihood of a 217	
horse changing egg shedding category were investigated (Model 1). In the final 218	
model, age (young horses ≥2 - <5 years) and last treatment with moxidectin were 219	
identified as significant explanatory variables (Table 2). Young horses (≥2 - < 5 220	
years) were more likely to change strongyle egg shedding category compared to foals 221	
(<2 years), adult horses (≥5 - <18 years) and geriatric horses (≥18 years, OR=3.3, 222	
95% CI=1.22 – 8.46, p=0.02), while horses that had received moxidectin at the last 223	
anthelmintic treatment were less likely to change strongyle egg shedding category 224	
compared to those that received ivermectin or pyrantel (OR=0.15, 95% CI=0.05-0.17, 225	
p<0.0001). Factors affecting the likelihood of a horse changing treatment category 226	
between S1 and S3 were also investigated (Model 2). In the final model (Table 2), 227	
young horses (≥2 - < 5 years) were more likely to change treatment category 228	
compared to foals (<2 years), adult horses (≥5 - <18 years) and geriatric horses (≥18 229	
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years, OR=2.8, 95% CI = 1.1-6.3, p=0.03) and horses that received moxidectin as 230	
their last treatment were significantly less likely to change treatment group compared 231	
to horses that received ivermectin or pyrantel (OR=0.15, 95% CI=0.1-0.4, p <0.0001). 232	
 233	
4. Discussion 234	
Knowledge that horses shed strongyle eggs at consistent levels over time can help 235	
underpin evidence-based targeted treatment control programmes [23]. Currently, 236	
FEC-directed targeted treatment programmes are recommended for adult horses, 237	
whereby individuals are screened for strongyle egg shedding every 4-6 weeks during 238	
the grazing season, and those excreting ≥200 epg treated with anthelmintic [10]. Here, 239	
strongyle egg shedding in horses, analysed over three to four sampling occasions 240	
within a grazing season, was found to be consistent. These results agree with those of 241	
previous studies which sampled horses over longer periods (1–3 years) [12-14] and 242	
shorter periods [11]. Each of these studies reported a high level of shedding 243	
consistency in horses sampled from the general population. One study reported that, if 244	
the first two FEC were 0 epg, there was an 82% probability that the third FEC would 245	
be 0 epg and a 91% chance that it would be <200 epg. Additionally, these authors 246	
found that if the first two counts were <200 epg, there was an 84% chance that the 247	
next FEC would be <200 epg, and if the first two FEC were ≥200 epg, there was a 248	
59% probability that the next FEC would be ≥200 epg [12]. This latter study 249	
demonstrated that egg shedding was consistent over a longer sampling period 250	
compared to that of the current one, particularly in horses that were measured as 251	
shedding 0 epg at the start. In a later survey [13], which followed a similar sampling 252	
time frame to ours, horses were treated with anthelmintic when the FEC was 253	
measured as ≥250 epg and only data from horses that did not receive anthelmintic 254	
	 12
were analysed. The authors reported that if the first two FEC were 0 epg, there was a 255	
62% probability that the maximum FEC of the next seven samples would be 0 epg, 256	
and if the first two FEC were 0 epg, there was an 88% probability that the maximum 257	
FEC of the next seven counts would be <200 epg. The authors concluded that, for 258	
individual horses, the magnitude of the initial FEC was significantly positively 259	
correlated to the maximal FEC of the subsequent eight counts [13]. In a further study, 260	
the repeatability of strongyle egg counts was assessed in naturally infected horses 261	
[14]. In that study, samples were collected over nine consecutive months, and 262	
analysed using a McMaster method with an egg count detection limit of 20 epg. These 263	
authors defined repeatability as the variance between horses divided by the total 264	
variance, meaning that a value of 0 indicates no consistency in FEC and a value of 1 265	
indicates perfect consistency. Using raw egg counts (i.e. the number of actual eggs 266	
counted before applying the multiplication factor), the within-horse repeatability was 267	
0.52 in all horses and 0.53 when horses that had received treatment were excluded 268	
from the analysis [14]. Despite each of the studies described following different 269	
counting methodology and distinctive statistical analyses, all demonstrate that 270	
strongyle egg shedding in horses was consistent over short and longer sampling time-271	
frames, especially in low egg shedding categories, indicating that such horses tend to 272	
excrete low numbers of eggs in the absence of anthelmintic treatment, over a 273	
prolonged period. In contrast to these reports, one study examined strongyle egg 274	
shedding consistency in ponies managed for conservation purposes, which remained 275	
largely untreated with anthelmintic over several years, and found that shedding 276	
consistency at individual level was generally weak [7]. In that study, FEC data were 277	
analysed using general additive mixed models to estimate repeatability of FEC at 278	
individual level and to test for differences in mean FEC amongst populations and age 279	
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classes. Climate and season were found to exert a significant effect on FECs 280	
measured in individuals in populations that did not receive anthelmintic and a strong 281	
interaction was identified between age and climate. The lack of individual consistency 282	
observed by Wood et al. (2013) compared with other studies [11-14] could be due to 283	
the length of time over which the data were collected, the FEC method used, the 284	
absence of anthelmintic treatments, the type of statistical analysis undertaken, or the 285	
nature of and level of exposure to parasite infection.  286	
Past studies investigating strongyle egg shedding consistency focused on estimates of 287	
strongyle FEC using McMaster methods with egg detection limits (dl) between 20 288	
and 50 epg [7, 11-14]. In the current study, a more sensitive count method was used. 289	
FEC generated using McMaster methods tend to generate higher epg estimates and 290	
greater variance. In addition, using a FEC method with a higher egg dl (i.e. 291	
multiplication factor), the methodology will be less sensitive to relatively small 292	
changes in egg abundance, and larger multiplication factors will artificially inflate 293	
variance [6, 24]. This may potentially lead to lower observed consistency between 294	
egg counts from the same individual over time because of the greater degree of 295	
artefactual variation in FEC. On the other hand, the higher number of false negative 296	
FEC arising from the limited dl of traditional McMaster methods could artificially 297	
increase apparent consistency of 0 measured epg over time in low-shedding horses. In 298	
the present study, measures were taken to ensure samples were collected, stored and 299	
processed in a way to minimise egg degradation [17], to ensure that a representative 300	
sample was collected to reduce egg clumping in faeces [10], and to minimise the 301	
effects of rounding error by using a very sensitive FEC method. However, the way in 302	
which the samples were collected and handled on each yard on each sampling 303	
occasion could have impacted the consistency of the results. 304	
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Here, egg shedding consistency was higher in adult and geriatric horses compared to 305	
youngsters. This lower level of consistency in FEC shedding in younger horses could 306	
be related to lower immunity [25] compared with older horses, such that variation in 307	
parasite challenge is less buffered and feeds through to downstream variation in FEC. 308	
In the current study, horses that were treated with moxidectin prior to the start of the 309	
study were less likely to change shedding or treatment category compared to those 310	
that had been treated with ivermectin or pyrantel. A likely reason for this is that 311	
shedding would be lower in horses previously treated with moxidectin due to its 312	
persistent effect against parasites in vivo [26]. Moxidectin has an elimination half-life 313	
of 23.11 days compared to ivermectin (4.25 days) and pyrantel (13.43 hours) [26]. 314	
This means that parasites are exposed to active anthelmintic for longer periods; hence 315	
the greater strongyle ERP observed after moxidectin treatment [26]. Moxidectin 316	
exhibits higher larvicidal activity compared to the other two anthelmintics. 317	
particularly against mucosal larvae [26-28]. This will also affect the strongyle ERP 318	
observed after moxidectin administration compared to other equine anthelmintics [26, 319	
29]. 320	
Recruitment of yards was non-random, being through veterinary practices and the 321	
BHS website. Nevertheless, there was heterogeneity in the yards recruited, which is 322	
likely to have provided a fairly representative sample of the UK equine population, 323	
outside breeding establishments, which have a younger age profile [6]. As such, 324	
further research is required to assess consistency of strongyle egg shedding in 325	
populations on breeding farms. 326	
It should be noted that the FEC data collected here were obtained over a single 327	
grazing season, and the effect of season and climate were not accounted for, both of 328	
which can impact on strongyle egg shedding patterns [7]. Furthermore, the effects of 329	
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management practices such as removal of faeces from pasture were not investigated, 330	
which has been shown to significantly reduce FEC in donkeys that grazed pasture 331	
where dung was removed twice-weekly by reducing larval populations on pasture 332	
[30]. Long-term studies investigating strongyle egg shedding patterns taking account 333	
of season, climate and management practices are warranted as these factors impact the 334	
intensity of larval contamination on pasture, which will in turn affect the egg 335	
shedding intensity downstream. This will help to better inform FEC-directed targeted 336	
anthelmintic treatment programmes, and to understand the appropriate frequency of 337	
FEC testing. 338	
In conclusion, egg shedding and treatment status at individual level were found to be 339	
relatively consistent, especially in adult horses, regardless of whether or not they had 340	
been treated with anthelmintic, indicating that horses with negative or low FEC (<50 341	
epg) initially were significantly more likely to have low FEC on subsequent 342	
occasions, and horses with a high FEC (≥200 epg) were significantly more likely to 343	
have a high FEC on subsequent occasions. Further, an adult horse not requiring 344	
anthelmintic treatment initially (based on a 200 epg threshold), would be less likely to 345	
require treatment on subsequent occasions in that season. These findings would 346	
suggest that the majority of adult horses are able to regulate their strongyle burden, 347	
leading to a maintained low FEC status. There is a lack of published information on 348	
long term patterns of strongyle egg shedding in equine populations, especially in 349	
horses managed under FEC-directed anthelmintic treatment programmes; this should 350	
be assessed in future, particularly in horses that are not receiving regular anthelmintic 351	
treatments. 352	
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Tables  448	
Table 1. Variables included in the initial logistic regression model 449	
Variable Responses 
Age category Foal (<2 years), youngster (≥2 and <5 
years), adult (≥5 and < 18 years) and 
geriatric (≥18 years). 
Last anthelmintic class administered IVM, MOX, PYR 
Time since expected *ERP elapsed Weeks 
Notes: *Egg reappearance period (ERP); ivermectin (IVM); moxidectin (MOX), pyrantel (PYR) 
 450	
 451	
 452	
 453	
  454	
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Table 2. Factors significantly affecting the odds of a horse changing egg shedding 455	
category (Model 1) and treatment category (Model 2) between sampling occasions S1 456	
and S3 as assessed by logistic regression. For each significant variable, the logit 457	
coefficient, the standard error (SE), the odds ratio (OR) and associated 95% 458	
confidence intervals (CI), and the significance (p<0.05) are presented. 459	
Model 
(Fit1) 
Significant 
variable 
Factor Logit 
coefficient 
(SE) OR 
(95% CI) 
p 
(Wald) 
1 (0.11)   1.44 0.27 Na <0.0001
 Age Youngsters 
(2-5 years) 
1.20 0.55 3.3 
(1.22 – 8.46) 
0.02 
(LRT) 
 Last 
treatment 
 
MOX 
 
-1.90 
 
0.31 
 
0.15 
(0.05-0.17) 
 
<0.0001
2 (0.38)   1.48 0.22 Na <0.0001 
 Age Youngsters 
(2-5 years) 
1.04 0.47 2.8 
(1.1 - 6.3) 
0.028 
(LRT) 
 Last 
treatment 
 
MOX 
 
-1.89 
 
0.61
 
0.15 
(0.1 – 0.4) 
 
<0.0001 
Notes: 1 Model fit was assessed using the Hosmer and Lemeshow test. MOX = moxidectin, 
SE=standard error, OR = odds ratio, Na= not applicable; LRT = likelihood ratio test. 
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Figure Captions 461	
 462	
Figure 1. The percentage of horses that fell into each strongyle egg shedding category (1-7) 463	
on each screening occasion (S1-S4), with category 1 (<49 eggs per gram (epg) represented by 464	
the darkest shade of grey and subsequent categories in lighter shades (A). The percentage of 465	
horses that were either shedding <200 epg (Category 0, dark grey) or ≥200 epg (Category 2, 466	
light grey) as measured by faecal egg count (FEC) on each screening occasion (B). The width 467	
of the bars is proportional to the number of observations per screening occasion. No statistical 468	
differences (p<0.05) in proportions between screening occasions as determined by the 469	
binomial test were observed.  470	
 471	
Figure 2. The rank change in egg shedding category and treatment category between 472	
sampling occasions (S1 and S2, S1 and S3 and S1 and S4). The percentage of horses either 473	
remained in the same egg shedding category (0), increased egg shedding category (1 to 6) or 474	
decreased egg shedding category (-1 to -6), with a rank change in -6 categories represented by 475	
the darkest shade of grey and subsequent ascending categories in lighter shades (A). The 476	
percentage of horses that were either remained in the same treatment category (0, mid-grey), 477	
increased in treatment category (1, light grey) or decreased in treatment category (-1, dark 478	
grey) (B) as measured by faecal egg count (FEC) on each screening occasion. The width of 479	
the bars is proportional to the number of observations per screening occasion. There were no 480	
statistical differences (p<0.05) in proportions between screening occasions as determined by 481	
the binomial test. 482	
 483	
